Bristol-Myers Squibb Given New $55.00 Price Target at Leerink Swann (BMY)
Investment analysts at Leerink Swann decreased their target price on shares of Bristol-Myers Squibb (NYSE:BMY) from $62.00 to $55.00 in a note issued to investors on Tuesday. Leerink Swann’s price objective would suggest a potential upside of 14.92% from the stock’s previous close.
Several other analysts have also recently commented on the stock. Analysts at Barclays downgraded shares of Bristol-Myers Squibb from an “overweight” rating to an “equal weight” rating in a research note on Wednesday, July 2nd. They now have a $46.00 price target on the stock, down previously from $65.00. Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of Bristol-Myers Squibb in a research note on Tuesday, June 24th. They now have a $42.00 price target on the stock, down previously from $47.00. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Bristol-Myers Squibb in a research note on Friday, June 20th. They now have a $50.00 price target on the stock. Eight equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $52.35.
Shares of Bristol-Myers Squibb (NYSE:BMY) traded down 0.31% on Tuesday, hitting $47.86. The stock had a trading volume of 6,872,546 shares. Bristol-Myers Squibb has a one year low of $41.11 and a one year high of $57.49. The stock has a 50-day moving average of $48.22 and a 200-day moving average of $51.20. The company has a market cap of $79.312 billion and a P/E ratio of 27.75.
Bristol-Myers Squibb (NYSE:BMY) last released its earnings data on Tuesday, April 29th. The company reported $0.46 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.43 by $0.03. The company had revenue of $3.81 billion for the quarter, compared to the consensus estimate of $3.89 billion. During the same quarter last year, the company posted $0.41 earnings per share. Bristol-Myers Squibb’s revenue was down .5% compared to the same quarter last year. On average, analysts predict that Bristol-Myers Squibb will post $1.78 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, August 1st. Stockholders of record on Thursday, July 3rd will be paid a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 3.01%. The ex-dividend date is Tuesday, July 1st.
Bristol-Myers Squibb Company (NYSE:BMY) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.